Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Хирурги собрались на Венском симпозиуме, чтобы испытать герметизирующее гемостатическое изделие HEMOPATCH от Baxter Нам доверяют уже более десяти лет Уже более десяти лет герметизирующее гемостатическое изделие Hemopatch является надежным помощником хирургов во...

Key Takeaway: Baxter's Hemopatch has gained the trust of surgeons worldwide for over a decade. This surgical product is noted for its effectiveness in providing essential support and precision during operations. As it continues to evolve, Hemopatch remains a vital tool in the medical field, ensuring patient safety and improved surgical outcomes.
Price reaction · baseline $24.18 (2025-08-15 close) · clean, no other BAX news in the window
day 0 close · peak
-2.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Hemopatch has been trusted by surgeons for over ten years.
  • It provides critical support and accuracy in surgical procedures.
  • The product is recognized globally for its reliability.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+18%
120-day peak, hindsight
Typical move
1.9%
average across 12 past catalysts
Lead asset
Dianeal
Phase 3 · End Stage Renal Disease (ESRD)

Full Press Release Details

ДИРФИЛД, штат Иллинойс , 18 августа 2025 г. /PRNewswire/ --
Нам доверяют уже более десяти лет Уже более десяти лет герметизирующее гемостатическое изделие Hemopatch является надежным помощником хирургов во всем мире, обеспечивая важнейшую поддержку и точность под давлением и при этом развиваясь вместе со здравоохранением.

Frequently Asked Questions

How long has Hemopatch been trusted by surgeons?

Hemopatch has been trusted by surgeons for over ten years.

What is the main benefit of using Hemopatch?

Hemopatch provides critical support and accuracy during surgical procedures.

Is Hemopatch recognized globally?

Yes, Hemopatch is recognized worldwide for its reliability in surgeries.

Last updated: Aug 18, 2025